InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: roiresearch post# 322357

Saturday, 09/05/2020 8:44:54 AM

Saturday, September 05, 2020 8:44:54 AM

Post# of 403018
Pinksheet stocks are a tough sell, but not impossible. IPIX doesn't have a rosy past of being able to execute. The amount of news that has come out compared to the PPS says the market doesn't really believe in B for C. I think once the FDA gets involved and not a variety of unnamed labs (RBL, PHRI, University) then the PPS goes on to make new heights. Maybe the unveiling of all the labs involved when the preprint is made available will have a positive impact on price along with confirmation of data investors have seen to date via vague PR's.

Trying to rationalize why there was no PR stating the RBL is done. Was testing delayed? Is testing done? Was it determined additional data was needed? I am not a long time investor here but it is clear the ceo is not one to disclose 'not so great info.' Is everything happening so slow? Is everything happening so fast that it's best to collect all the pieces before issuing the next PR for the best impact? Are we waiting for pre-print before issuing next PR to avoid the doubting Thomas?

IPIX will have it's day in the sun (or more likely a good run). We are all being exhausted by the dwindling pps yet amazing potential. i chose to pre-occupy myself so as not to watch tick by tick possibly 2nd guessing my decision to believe in B for C as well as the pipeline. TIme will tell. In a month i am happy to say i was wrong.

the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News